1. |
J. Du, Z. Shao, and H. Zhao. “Engineering a Microbial Factory for Synthesis of Value-added Products.” Journal of Industrial Microbiology and Biotechnology, 38, 873-890 (2011). |
|
|
2. |
T. Si, Y. Luo, and H. Xiao, and H. Zhao. “Utilizing an Endogenous Pathway for 1-Butanol Production in Saccharomyces cerevisiae.” Metabolic Engineering, 22, 60-68 (2014). |
|
|
3. |
X. Feng, J. Lian, and H. Zhao. “Metabolic Engineering of Saccharomyces cerevisiae to Improve 1-Hexadecanol Production.” Metabolic Engineering, 27, 10–19 (2015). |
|
|
4. |
T. Si, Y. Luo, Z. Bao, and H. Zhao. “RNAi-Assisted Genome Evolution in Saccharomyces cerevisiae for Complex Phenotype Engineering.” ACS Synthetic Biology, DOI: 10.1021/sb500074a. |
|
|
5. |
T. Si, H. Xiao, and H. Zhao. “Rapid Prototyping of Microbial Cell Factories via Genome-scale Engineering.” Biotechnology Advances, DOI:10.1016/j.biotechadv.2014.11.007. |
|
|
6. |
R. E. Cobb and H. Zhao. “Direct Cloning of Large Genomic Sequences.” Nature Biotechnology, 30, 405-406 (2012). |
|
|
7. |
Y. Luo, H. Huang, J. Liang, M. Wang, L. Lu, Z. Shao, R.E. Cobb, and H. Zhao. “Activation and Characterization of a Cryptic Polycyclic Tetramate Macrolactam Biosynthetic Gene Cluster.” Nature Communications, 4: 2894 (2013). |
|
|
8. |
Z. Abil, X. Xiong, and H. Zhao. “Synthetic Biology for Therapeutic Applications.” Molecular Pharmaceutics, 12, 322−331 (2015). |
|
|
9. |
N. Sun and H. Zhao. “Transcription Activator-like Effector Nucleases (TALENs): A Highly Efficient and Versatile Tool for Genome Editing.” Biotechnology and Bioengineering, 110, 1811-1821 (2013). |
|
|
10. |
N. Sun, J. Liang, Z. Abil, and H. Zhao. “Optimized TAL Effector Nucleases (TALENs) for Use in Treatment of Sickle Cell Disease.” Molecular Biosystems, 8, 1255 – 1263 (2012). |
|
|
11. |
Z. Bao, H. Xiao, J. Liang, X. Xiong, N. Sun, T. Si, and H. Zhao.“A Homology Integrated CRISPR-Cas (HI-CRISPR) System for One-step Multi-gene Disruptions in Saccharomyces cerevisiae.” ACS Synthetic Biology, DOI: 10.1021/sb500255k |
|